In our research, we found that ENTPD8 may regulate the expression of miR-214-5p, thereby affecting the expression of PD-L1 and enhancing the sensitivity of HCC cells to PD-L1 therapy. The gene discussed is CD274; the disease is hepatocellular carcinoma.